Αποτελέσματα Αναζήτησης
16 Ιουλ 2024 · Here, we assessed humoral immune response to SARS-CoV-2 infection comparing acute- and convalescent-phase IgG antibody levels against N and ancestral S RBD antigens among case patients infected during Omicron variant–predominant periods from December 2021 through June 2022.
31 Ιουλ 2023 · Here, we aimed to identify human antibodies (hAbs) from convalescent patients that are potent and broadly neutralizing toward Omicron sublineages. Using a single B-cell cloning approach, we isolated BA.5 specific human antibodies.
20 Οκτ 2022 · We show that hybrid immunity or vaccine boosters elicit plasma-neutralizing antibodies against Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5, and that breakthrough infections, but not vaccination alone, induce neutralizing antibodies in the nasal mucosa.
1 Αυγ 2023 · Our data provide a comprehensive overview of the longitudinal viral and antibody dynamics of omicron variant in people with acute SARS-CoV-2 infection, with important implications for public health strategies, including population screening, antiviral treatment, isolation periods, and vaccination.
7 Ιαν 2023 · In this study, we collected sera from individuals in the acute or convalescent phase after BA.2-breakthrough infection and then detected levels of antibodies and their neutralizing ability,...
21 Νοε 2024 · The susceptibility of SARS-CoV-2 spikes to neutralization by antibodies generated from exposure to SARS-CoV-2 spike variants with unique immunodominant regions (i.e. Beta, Delta, Omicron, etc ...
1 ημέρα πριν · The changes sensitizing viruses to stem-helix antibody neutralization were within the Omicron BA.1 S1CD, far from the antibody binding epitope . This was evident from the hypersensitivity of D614G chimeras harboring Omicron S1CD ( Fig 2B ; blue trendline) and the relative resistance of Omicron BA.1 chimeras with D614G S1CD ( Fig 2C ; blue ...
